Deerfield Management as of Sept. 30, 2017
Portfolio Holdings for Deerfield Management
Deerfield Management holds 90 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Avexis | 6.7 | $150M | 1.5M | 96.73 | |
McKesson Corporation (MCK) | 5.3 | $119M | 772k | 153.61 | |
Mylan Nv | 4.5 | $99M | 3.2M | 31.37 | |
Horizon Pharma | 4.0 | $88M | 6.9M | 12.68 | |
Glaukos (GKOS) | 3.8 | $83M | 2.5M | 33.00 | |
Dex (DXCM) | 3.1 | $70M | 1.4M | 48.92 | |
Mallinckrodt Pub | 3.1 | $70M | 1.9M | 37.37 | |
Horizon Pharma Plc convertible security | 3.0 | $67M | 74M | 0.90 | |
Myokardia | 2.6 | $59M | 1.4M | 42.85 | |
Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.2 | $48M | 46M | 1.06 | |
Kempharm Inc note 5.500% 2/0 | 2.1 | $46M | 75M | 0.61 | |
NxStage Medical | 2.0 | $44M | 1.6M | 27.60 | |
Audentes Therapeutics | 1.9 | $43M | 1.5M | 28.01 | |
Editas Medicine (EDIT) | 1.9 | $41M | 1.7M | 24.01 | |
Aclaris Therapeutics (ACRS) | 1.8 | $41M | 1.6M | 25.81 | |
Intercept Pharmas conv | 1.8 | $40M | 51M | 0.78 | |
Trn 4% 04/01/45 | 1.7 | $38M | 48M | 0.80 | |
Flamel Technologies Sa | 1.7 | $38M | 3.7M | 10.50 | |
Intersect Ent | 1.7 | $38M | 1.2M | 31.15 | |
Gw Pharmaceuticals Plc ads | 1.7 | $37M | 363k | 101.49 | |
Endologix, Inc. 3.25% 11/01/2020 | 1.6 | $35M | 41M | 0.86 | |
Nevro Corp note 1.750% 6/0 | 1.5 | $33M | 28M | 1.19 | |
Aerie Pharmaceuticals | 1.4 | $31M | 633k | 48.60 | |
Ascendis Pharma A S (ASND) | 1.4 | $31M | 850k | 36.25 | |
Anaptysbio Inc Common (ANAB) | 1.3 | $29M | 824k | 34.95 | |
Natera (NTRA) | 1.3 | $28M | 2.2M | 12.89 | |
Dbv Technologies S A | 1.2 | $28M | 656k | 42.44 | |
Insulet Corporation (PODD) | 1.2 | $27M | 497k | 55.08 | |
Arena Pharmaceuticals | 1.2 | $27M | 1.1M | 25.50 | |
Lannett Company | 1.2 | $27M | 1.5M | 18.45 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $26M | 5.0M | 5.24 | |
K2m Group Hldgs Inc bond | 1.1 | $24M | 20M | 1.22 | |
Select Medical Holdings Corporation (SEM) | 1.0 | $23M | 1.2M | 19.20 | |
Acceleron Pharma | 1.0 | $23M | 615k | 37.32 | |
Patterson Companies (PDCO) | 1.0 | $22M | 566k | 38.65 | |
Fluidigm Corporation convertible cor | 0.9 | $20M | 28M | 0.73 | |
Syros Pharmaceuticals | 0.8 | $19M | 1.3M | 14.72 | |
Molina Healthcare (MOH) | 0.8 | $18M | 258k | 68.76 | |
Aac Holdings | 0.8 | $17M | 1.7M | 9.93 | |
Selecta Biosciences | 0.8 | $17M | 952k | 18.25 | |
Recro Pharma | 0.8 | $17M | 1.9M | 8.98 | |
Portola Pharmaceuticals | 0.7 | $16M | 299k | 54.03 | |
Synlogic | 0.7 | $16M | 850k | 19.01 | |
eHealth (EHTH) | 0.7 | $16M | 673k | 23.89 | |
Oxford Immunotec Global | 0.7 | $16M | 946k | 16.80 | |
Amag Pharmaceuticals Inc note 2.500% 2/1 | 0.7 | $16M | 16M | 0.97 | |
Loxo Oncology | 0.7 | $16M | 169k | 92.12 | |
Ardelyx (ARDX) | 0.7 | $15M | 2.7M | 5.60 | |
Advanced Accelerat spon ads each rep 2 ord | 0.7 | $15M | 218k | 67.62 | |
Neos Therapeutics | 0.7 | $14M | 1.6M | 9.15 | |
Blueprint Medicines (BPMC) | 0.6 | $14M | 203k | 69.67 | |
Agios Pharmaceuticals (AGIO) | 0.6 | $14M | 208k | 66.75 | |
Cytomx Therapeutics (CTMX) | 0.6 | $14M | 757k | 18.17 | |
Epizyme | 0.6 | $13M | 701k | 19.05 | |
Galapagos Nv- (GLPG) | 0.6 | $13M | 130k | 101.75 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.6 | $13M | 17M | 0.80 | |
Wave Life Sciences (WVE) | 0.6 | $13M | 580k | 21.75 | |
Xencor (XNCR) | 0.5 | $12M | 522k | 22.92 | |
Argenx Se (ARGX) | 0.5 | $12M | 509k | 22.61 | |
Alpine Immune Sciences | 0.5 | $11M | 933k | 11.60 | |
Invuity | 0.5 | $11M | 1.2M | 8.90 | |
Allscripts Healthcare So conv | 0.5 | $10M | 9.7M | 1.06 | |
Sangamo Biosciences (SGMO) | 0.4 | $9.8M | 653k | 15.00 | |
Centene Corporation (CNC) | 0.4 | $9.9M | 102k | 96.77 | |
Invitae (NVTAQ) | 0.4 | $8.4M | 900k | 9.37 | |
Immunomedics | 0.4 | $8.1M | 582k | 13.98 | |
Alimera Sciences | 0.4 | $8.2M | 6.1M | 1.35 | |
Marinus Pharmaceuticals | 0.4 | $8.0M | 1.4M | 5.87 | |
Nucana Plc american depositary shares | 0.3 | $7.8M | 425k | 18.37 | |
Clementia | 0.3 | $7.8M | 462k | 16.89 | |
Axovant Sciences | 0.3 | $7.2M | 1.1M | 6.88 | |
Axogen (AXGN) | 0.3 | $6.7M | 344k | 19.35 | |
Myovant Sciences | 0.3 | $6.2M | 401k | 15.47 | |
Biohaven Pharmaceutical Holding | 0.3 | $6.2M | 165k | 37.38 | |
Deciphera Pharmaceuticals | 0.3 | $6.2M | 325k | 18.99 | |
Reata Pharmaceuticals Inc Cl A | 0.3 | $5.9M | 190k | 31.10 | |
Agile Therapeutics | 0.2 | $5.4M | 1.2M | 4.46 | |
Steadymed | 0.2 | $4.8M | 1.4M | 3.35 | |
Foamix Pharmaceuticals | 0.2 | $4.5M | 817k | 5.55 | |
Sierra Oncology | 0.2 | $4.3M | 2.8M | 1.55 | |
Sage Therapeutics (SAGE) | 0.2 | $4.2M | 68k | 62.29 | |
Aralez Pharmaceuticals | 0.2 | $3.8M | 1.6M | 2.29 | |
Obalon Therapeutics | 0.1 | $3.3M | 351k | 9.53 | |
BioScrip | 0.1 | $3.0M | 1.1M | 2.75 | |
Akari Therapeutics | 0.1 | $2.7M | 434k | 6.14 | |
Proteon Therapeutics | 0.1 | $2.4M | 1.2M | 2.00 | |
Voyager Therapeutics (VYGR) | 0.1 | $2.4M | 118k | 20.59 | |
MiMedx (MDXG) | 0.1 | $1.8M | 150k | 11.88 | |
Intra Cellular Therapies (ITCI) | 0.1 | $1.9M | 118k | 15.78 | |
Ra Pharmaceuticals | 0.1 | $1.5M | 102k | 14.60 |